World-Class CDMO Services in India for Russia
CDMO и производство АФИ в Индии для России | WHO-GMP
Shilpa Pharma delivers high-quality, compliant, and scalable CDMO services from India to Russian pharmaceutical and biotech companies. As a globally trusted Contract Development and Manufacturing Organization (CDMO), we operate in full alignment with international regulatory authorities including WHO-GMP, US FDA, EU GMP, and other leading global agencies, ensuring products meet stringent quality and compliance expectations.
By combining deep scientific expertise, advanced manufacturing technologies, and robust quality systems, we help Russian partners accelerate product development, support regulatory submissions, and secure reliable global supply. Our cost-efficient pharmaceutical outsourcing model and long-term partnership approach strengthen supply chains and enable faster, compliant commercialization.
Our CDMO Specialties
- High pressure reaction with Pd/Ru/Rd etc., Hydrogenation
- Brominating/Chlorination
- Cyanation
- Electro-chemical reactions
- Asymmetric synthesis
- Cryogenic reactions (up to -90°C)
- Boron Chemistry
- Hydrogenation including asymmetric capabilities
- Butyl Lithium Reaction
- Chiral Synthesis
- Cyclopropane Chemistry
- Grignard Reaction
- Indole Chemistry
- Nucleoside Chemistry
- Purine Chemistry
- Pyridine Chemistry
- Pyrimidine Chemistry
- Steroid Chemistry
- Oxidation and reduction reactions
- Pressure reactions
- Enzymatic reactions
- Use of phase transfer catalyst
- Cytotoxic (Onco) products Can handle with isolators.
Have Questions? We’re Here to Help
Get a Quote
Happy Customers
Projects Successfully Completed
Established
PhD Experts Driving R&D Excellence
Team Size
World-Class API Manufacturing Sites
Global Audits Successfully Completed
Comprehensive CDMO Service Offerings
Shilpa Pharma Globally Accredited CDMO Partner
Shilpa Pharma’s facilities operate under multiple global regulatory certifications, reflecting our commitment to quality and compliance. This global compliance framework makes Shilpa Pharma a preferred CDMO partner for Russian companies seeking regulated-grade manufacturing capabilities from India.
Why Shilpa Pharma is Your Trusted CDMO Partner Across the Globe
As a globally accredited CDMO based in India, Shilpa Pharma supports Russia pharmaceutical companies with end-to-end, compliant, and cost-effective manufacturing solutions. Our expertise in complex chemistries, advanced formulations, and regulated market requirements ensures consistent quality and reliable supply.
End-to-End CDMO Solutions
From route scouting to GMP manufacturing, we cover every stage of drug development.
State-of-the-Art R&D
Advanced laboratories for formulation, biologics, and peptide research.
Global Quality Standards
GMP-compliant facilities ensuring regulatory-ready production.
Advanced Manufacturing Capabilities
High-potent APIs, continuous flow chemistry, and scalable processes.
Sustainable & Compliant Operations
Environmentally responsible practices with stringent safety protocols.
Trusted by Pharma Innovators
Reliable partnerships delivering complex projects on time and within budget.
CMO Contract Manufacturing Organization India to Russia
Shilpa Pharma is recognized as a world-class Contract Manufacturing Organization in India, trusted by Russian and global pharmaceutical companies for precision manufacturing, consistent reliability, and uncompromised regulatory compliance. As a preferred CDMO partner, we deliver end-to-end contract manufacturing solutions that meet international quality standards and ensure dependable supply.
Our state-of-the-art manufacturing facilities enable the production of complex APIs, advanced oncology compounds, and specialty intermediates that only a limited number of manufacturers globally can deliver. From raw material sourcing to final packaging, every process is managed with transparency, robust documentation, and strict quality control—ensuring exceptional batch-to-batch consistency and on-time delivery.
- Precision & Compliance: Manufacturing under stringent international regulatory guidelines
- Advanced Facilities: Capabilities for complex, high-value, and niche pharmaceutical products
- End-to-End Manufacturing: Seamless execution from tech transfer to commercial production.
CONTRACT DEVELOPMENT
Shilpa Pharma’s Contract Development services support Russian pharmaceutical companies with robust, compliant, and scalable development solutions aligned with global quality standards. Leveraging advanced R&D capabilities and GMP-certified facilities in India, we assist partners at every stage—from route scouting and process optimization to formulation development and pilot-scale manufacturing.
Our scientific strength lies in developing complex, rare, and high-value molecules, including oncology compounds and specialty intermediates that demand advanced technical expertise. Every development program is executed under strict international guidelines to ensure safety, purity, and reproducibility—laying a strong foundation for smooth technology transfer and commercial-scale manufacturing.
Questions & Answers
Our FAQ's
Everything You Need to Know About API Manufacturing in India at Shilpa Pharma
What CDMO services does Shilpa Pharma provide to Russian pharmaceutical companies?
Shilpa Pharma offers end-to-end CDMO services including custom development, API and formulation manufacturing, process optimization, analytical support, and large-scale production specifically tailored for the Russian market.
Is Shilpa Pharma compliant with global regulatory standards?
Yes. Our facilities hold certifications from USFDA, EU GMP, PMDA, and other major global regulatory bodies, ensuring international compliance for products intended for Russia and beyond.
Why partner with a CDMO in India for Russia?
Partnering with an India-based CDMO like Shilpa Pharma combines cost-efficiency, advanced technical capabilities, strong regulatory compliance, and reliable supply—ideal for Russian pharma and biotech companies.
Can Shilpa Pharma handle complex APIs for Russian partners?
Yes. We specialize in complex APIs, HPAPIs, oncology compounds, specialty intermediates, peptides, and high-potency manufacturing with advanced quality control and documentation.
Does Shilpa Pharma support technology transfer for Russian projects?
Absolutely. Our experienced teams ensure smooth technology transfer, scale-up support, and regulatory-ready processes optimized for Russian regulatory expectations.
